0001415889-21-003112.txt : 20210621
0001415889-21-003112.hdr.sgml : 20210621
20210621161031
ACCESSION NUMBER: 0001415889-21-003112
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210618
FILED AS OF DATE: 20210621
DATE AS OF CHANGE: 20210621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SOLAND DANIEL B
CENTRAL INDEX KEY: 0001318485
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 211030620
MAIL ADDRESS:
STREET 1: 4560 HORTON STREET,M/S R-422
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000861838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043072298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 EAGLEVIEW BOULEVARD
STREET 2: SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 4843481600
MAIL ADDRESS:
STREET 1: 505 EAGLEVIEW BOULEVARD
STREET 2: SUITE 212
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: HYBRIDON INC
DATE OF NAME CHANGE: 19951211
4
1
form4-06212021_040601.xml
X0306
4
2021-06-18
0000861838
IDERA PHARMACEUTICALS, INC.
IDRA
0001318485
SOLAND DANIEL B
C/O IDERA PHARMACEUTICALS, INC.
505 EAGLEVIEW BOULEVARD, SUITE 212
EXTON
PA
19341
false
true
false
false
CHIEF OPERATING OFFICER
Common Stock
2021-06-18
4
P
0
50000
1.19
A
78843
D
/s/ Daniel B. Soland
2021-06-21